Maishman, T., Stanton, L., Davies, A., Barrans, S., Worrillow, L., Mamot, C., . . . Johnson, P. (2013). A novel adaptive trial design: Randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy. BioMed Central.
Stile di citazione ChicagoMaishman, Tom, et al. A Novel Adaptive Trial Design: Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib (REMODL-B) With Two Interim Analyses to Explore Safety and Efficacy. BioMed Central, 2013.
Citazione MLAMaishman, Tom, et al. A Novel Adaptive Trial Design: Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib (REMODL-B) With Two Interim Analyses to Explore Safety and Efficacy. BioMed Central, 2013.